Natural Capsules Share Price Today | Stock Price & Natural Capsules Share Screener
As of September 1, 2026, the live Natural Capsules share price (NSE: NATCAPSUQ) is ₹201.37 on NSE and ₹167.90 on BSE, down 5.18% from the previous close, with shares trading between ₹192.00 and ₹216.79 in today's trading session, and a 52-week range of ₹140.04–₹214.16. Check NATCAPSUQ 52-week high low for the annual price range and momentum. Use the Natural Capsules stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Natural Capsules opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹59 and net income of ₹-5, with EBITDA of ₹2, an operating margin of 2.0% and a profit margin of -8.5%.
Natural Capsules Share Price Chart
Track the current stock price of Natural Capsules with an interactive chart. Analyse NATCAPSUQ share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Natural Capsules stock quote in one place.
The quote of ₹201.37 sits between the 52-week low of ₹140.04 and the 52-week high of ₹214.16, and the latest session moved -5.18% from the previous close.
Natural Capsules Company Profile - Fundamental Screener
Screen Natural Capsules company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NATCAPSUQ shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE936B01015.
Company Details
Classification
Identifiers and Leadership
Natural Capsules Balance Sheet Screener
Screen NATCAPSUQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹424, up from ₹419 in 2025.
Latest statistics put total assets at ₹424 and shareholder funds at ₹235, with a leverage ratio of 0.49.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
Assets |
|||||||||
| Total Assets | 424 | 419 | 377 | 289 | 164 | 97 | 75 | 73 | 71 |
| Current Assets | 137 | 130 | 124 | 102 | 76 | 42 | 38 | 38 | 42 |
| Fixed Assets | 274 | 284 | 103 | 97 | 67 | 38 | 24 | 24 | 22 |
Liabilities |
|||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 57 | 62 | 71 | 74 | 37 | 1 | 1 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||||
| Total Equity | 235 | 257 | 229 | 148 | 83 | 62 | 56 | 56 | 54 |
| Share Capital | 10 | 10 | 9 | 9 | 7 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 165 | 176 | 195 | 114 | 76 | 56 | 49 | 49 | 48 |
Natural Capsules Income Statement Screener - Profit & Revenue Analysis
Screen Natural Capsules income statement and profit fundamentals. Analyze NATCAPSUQ quarterly results. Natural Capsules reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹59 and net profit was ₹-5, equal to earnings per unit of ₹-4.82, at an operating margin of 2%.
In that period expenses were ₹57, interest cost ₹3 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹51 and net profit of ₹-6.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 59 | 51 | 45 | 46 | 46 | 38 | 41 | 39 | 41 | 44 | 38 | 38 | 38 | 41 | 42 |
| Expenses | 57 | 48 | 41 | 45 | 47 | 40 | 36 | 35 | 37 | 40 | 32 | 32 | 32 | 35 | 33 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 2 | 4 | 5 | 1 | -1 | -2 | 5 | 5 | 5 | 4 | 6 | 6 | 6 | 5 | 9 |
| Operating Profit % | 2.00% | 2.00% | 10.00% | 1.00% | -2.00% | -6.00% | 10.00% | 11.00% | 11.00% | 10.00% | 15.00% | 16.00% | 14.00% | 12.00% | 20.00% |
| Depreciation | 4 | 4 | 2 | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Interest | 3 | 5 | 2 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -5 | -6 | 1 | -6 | -8 | -9 | 1 | 1 | 1 | 1 | 3 | 3 | 2 | 2 | 7 |
| Tax | 0 | 0 | 0 | -1 | -1 | -2 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 2 |
| Net Profit | -5 | -6 | 1 | -6 | -7 | -7 | 1 | 1 | -1 | 0 | 2 | 2 | 2 | 1 | 5 |
| EPS | -4.82 | -5.55 | 0.13 | -5.40 | -6.76 | -6.88 | 1.31 | 0.65 | -0.60 | 0.10 | 1.85 | 1.96 | 1.67 | 1.29 | 7.02 |
Natural Capsules Cash Flow Screener - Liquidity Fundamentals
Screen NATCAPSUQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹11, and net cash flow was an outflow of ₹1.
Over the same period, investing activities used ₹11 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||||
| Operating Activities | 11 | 27 | -8 | 17 | -1 | 13 | 7 | 2 | 5 |
| Investing Activities | -11 | -45 | -73 | -105 | -46 | -16 | -6 | -7 | -1 |
Financing and Net Cash | |||||||||
| Financing Activities | -1 | 16 | 82 | 88 | 48 | 3 | -1 | 4 | -4 |
| Net Cash Flow | -1 | -2 | 1 | 0 | 1 | 0 | 0 | -1 | 1 |
Natural Capsules Shareholding Pattern Screener
See Natural Capsules shareholding pattern with promoter, FII, and DII holdings. Check Natural Capsules promoter holding and ownership changes for NATCAPSUQ on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 51.04%, foreign institutions 0.00%, domestic institutions 0.00% and the public 33.06%, spread across 8,850 shareholders.
The shareholder count was 8,850 in 2026-Mar, compared with 8,756 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Feb | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 51.04% | 50.92% | 51.14% | 51.21% | 51.26% | 51.26% | 51.26% | 56.56% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.31% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 33.06% | 33.23% | 32.86% | 33.09% | 33.04% | 32.94% | 32.95% | 34.72% |
| Other Holding | 15.90% | 15.85% | 16.01% | 15.70% | 15.69% | 15.80% | 15.79% | 7.41% |
| Shareholder Count | 8,850 | 8,756 | 9,552 | 9,425 | 9,311 | 9,573 | 9,075 | 10,954 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Natural Capsules. Natural Capsules dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹1.00 | 0.33% |
| 2022-March | ₹1.00 | 0.26% |
| 2021-March | ₹1.00 | 0.22% |
| 2020-March | ₹0.60 | 0.68% |
| 2019-March | ₹1.00 | 3.71% |
| 2018-March | ₹1.00 | 1.88% |
| 2017-March | ₹1.00 | 1.18% |
Natural Capsules Stock Index Membership - Nifty & Sensex
See which indices include Natural Capsules stock. Check NATCAPSUQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Natural Capsules Market Events Screener - Corporate Actions
Get Natural Capsules corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Natural Capsules stock events that may affect NATCAPSUQ share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Extraordinary General Meeting dated September 9, 2026, with a record date of September 9, 2026.
It is followed by Quarterly Result Announcement dated August 12, 2026 and Annual General Meeting dated August 12, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-09 | 2026-09-09 | Extraordinary General Meeting | NA | 18.08% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | 1.16% |
| 2026-08-12 | 2026-08-12 | Annual General Meeting | NA | 14.27% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | -8.33% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 0.63% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.85% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -0.46% |
| 2025-08-04 | 2025-08-04 | Annual General Meeting | NA | -3.27% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 2.49% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -10.56% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -4.42% |
| 2024-08-23 | 2024-08-23 | Extraordinary General Meeting | NA | -5.93% |
| 2024-07-26 | 2024-07-26 | Annual General Meeting | NA | 9.84% |
| 2023-07-20 | 2023-07-20 | Dividend | ₹ 1.00 /share | -19.69% |
| 2022-09-09 | 2022-09-13 | Dividend | ₹ 1.00 /share | 29.27% |
Natural Capsules Competitors Screener - Peer Stocks Comparison
Screen NATCAPSUQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,120 | 36.04 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 245,532 | 84.24 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 181,333 | 84.71 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 114,284 | 25.27 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,576 | 32.50 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 107,198 | 98.20 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,707 | 50.04 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,679 | 32.41 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,479 | 25.84 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,885 | 16.82 | 29,039 | 26.75% | 5,356 | 31.59 |
Natural Capsules Company Announcements - News & Reports Screener
Screen NATCAPSUQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 27, 2026.
The next most recent announcements are dated September 9, 2026 and September 9, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-27 | Closure of Trading Window | - |
| 2026-09-09 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-09-09 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-09-02 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday September 02 2026 At Shorter Notice | - |
| 2026-09-01 | Board Meeting Intimation for Intimation Under Regulation 29 And Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Board Meeting Scheduled At Shorter Notice On September 02 2026 | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-18 | Intimation Of Record Date For Extraordinary General Meeting (EGM) Is Fixed On September 2Nd 2026. | - |
| 2026-08-18 | Notice Of The Extraordinary General Meeting (EGM) Of The Company Scheduled To Be Held On Wednesday September 09 2026 At 12:00 PM (IST) | - |
| 2026-08-17 | Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Independent Director Of Material Unlisted Subsidiary. | - |
| 2026-08-16 | Results-Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-12 | Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-08-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday August 12 2026 | - |
| 2026-08-12 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹201.37, within a 52-week range of ₹140.04 to ₹214.16. The P/E ratio is -6.96 and the P/B ratio is 0.99, with earnings per unit of ₹-23.84. Market capitalisation stands at ₹168.83 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 9 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.